Nigatu Hulubanchi, Belay Alemnesh, Ayalew Hiwot, Abebe Besufekad, Tadesse Alemu, Tewabe Yitagesu, Degu Abel
Department of Pharmaceutical Chemistry and Pharmacognosy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
J Exp Pharmacol. 2021 Jan 15;13:15-22. doi: 10.2147/JEP.S285079. eCollection 2021.
Leishmaniasis is a group of diseases caused by protozoan parasites, which remains a burden for developing countries. The lack of a vaccine as well as the emergence of resistance toward the recommended drugs pose a challenge for the control of the disease. This urges the demand for new antileishmanial agents to prevent and treat this disease. Consequently, four Ethiopian plants were selected and tested for their antileishmanial activity against two Leishmanial parasites.
Methanol (80%) was used to macerate the plant materials. In vitro antipromastigote activity of the crude extracts was then tested against promastigotes and axenically cultured amastigotes of and clinical isolates using Alamar Blue assay, and cell viability was measured fluorometrically. 1% DMSO and the media were used as a negative control while amphotericin B was used as a positive control. Furthermore, preliminary phytochemical analysis of the extracts was performed.
From the four plants' extracts, and showed better activity with IC value of 11.38±0.55 and 13.03±0.87 µg/mL against , respectively. However, the same plant extracts exhibited lower activity against with IC values of 23.41±2.32 and 17.24±1.29 µg/mL, respectively. exhibited highest effect against amastigotes of (IC: 16.84±0.65) and (IC:14.55±0.38). resulted second highest in growth inhibition against amastigotes of and with IC value of 14.32±0.54 and 31.12±0.19, respectively. The phytochemical analysis of the extracts indicated the presence of phenol, flavonoids, tannins, saponins, terpenoids, and alkaloids.
The findings from this study demonstrate that crude extracts of and showed promising antileishmanial activity against and that may be attributed to the presence of different secondary metabolites.
利什曼病是由原生动物寄生虫引起的一组疾病,仍然是发展中国家的一个负担。缺乏疫苗以及对推荐药物产生耐药性对该疾病的控制构成了挑战。这促使人们需要新的抗利什曼病药物来预防和治疗这种疾病。因此,选择了四种埃塞俄比亚植物,并测试了它们对两种利什曼原虫寄生虫的抗利什曼病活性。
用80%甲醇浸泡植物材料。然后使用Alamar Blue测定法测试粗提物对两种临床分离株的前鞭毛体和无菌培养的无鞭毛体的体外抗前鞭毛体活性,并通过荧光法测量细胞活力。1%二甲基亚砜和培养基用作阴性对照,两性霉素B用作阳性对照。此外,对提取物进行了初步的植物化学分析。
从这四种植物提取物中,[植物名称1]和[植物名称2]表现出较好的活性,对[寄生虫名称1]的IC50值分别为11.38±0.55和13.03±0.87μg/mL。然而,相同的植物提取物对[寄生虫名称2]的活性较低,IC50值分别为23.41±2.32和17.24±1.29μg/mL。[植物名称3]对[寄生虫名称1]的无鞭毛体(IC50:16.84±0.65)和[寄生虫名称2]的无鞭毛体(IC50:14.55±0.38)表现出最高的效果。[植物名称4]对[寄生虫名称1]和[寄生虫名称2]的无鞭毛体生长抑制作用排名第二,IC50值分别为14.32±0.54和31.12±0.19。提取物的植物化学分析表明存在酚类、黄酮类、单宁类、皂苷类、萜类和生物碱类。
本研究结果表明,[植物名称1]和[植物名称2]的粗提物对[寄生虫名称1]和[寄生虫名称2]表现出有前景的抗利什曼病活性,这可能归因于不同次生代谢产物的存在。